Stock Updates

Today’s Top Gainers in the Market Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Healthcare

Today’s top gainers include the company Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) which is in the industry Biotechnology, gaining 0.12% today. In the last week its performance is 4.69%, and -3.22% for the past quarter. Currently, Regeneron Pharmaceuticals, Inc., REGN has a target price of 468.05, so today’s gain of 0.12% is a significant step towards its target price. The GAP today is therefore -0.08%.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), has a market cap of 40930.25, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 71.50%.

At the current price of 391.82, it has a dividend yield of *TBA, and its target price is 468.05. This is with a profit margin of 16.40%, and total debt/equity of 0.1. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a P/E of 62.15, as well as a forward P/E of 25.62.

With a current EPS of 6.3, and a forecasted EPS growth for next year at 41.71%,Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has had a EPS growth for the past five years at 44.90%. For the next five years EPS growth is projected to be 19.09%.

Performance for the year is -29.69%. Since its IPO date on 4/2/1991, the total performance to date is -27.91%.

Volume today for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), is 129317, while its average volume is 893.87. Whilst the total gain today was 0.12%, it did have a day high of -4.05%.

Volatility for this week has been at 2.48%, and 2.60% for the month. The 52-week low for Regeneron Pharmaceuticals, Inc., REGN has been 19.06%, while the 52-week-high has reached -35.34%.

Looking at its return of investments, which is 16.00%, and its return on assets is 13.70%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has an operating margin of 28.90%. With a sales growth of 38.10% quarter over quarter. Bearing in mind that Regeneron Pharmaceuticals, Inc., REGN is in the sector Healthcare, its long-term debt/equity is 0.1, and has a current ratio of 3.4 and 3.1 for quick ratio.

So what is the value of Regeneron Pharmaceuticals, Inc.? Well its PEG is 3.26, and the P/S is 9.23, along with a P/B of 10.84. Meanwhile it has a p/cash of 48.2.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment